What is the ticker symbol for Genfit S.A.?

Genfit S.A. trades under the ticker GNFT on NASDAQ.

What sector does Genfit S.A. operate in?

Genfit S.A. is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze GNFT in a portfolio?

PortView shows GNFT's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Genfit S.A. (GNFT) Stock Analysis

NASDAQHealthcareBiotechnology

$8.95+4.07%

1-year price historyRange $2.72 – $6.41

52-week range$8.95

$2.55$10.00

What Genfit S.A. does

Genfit S.A. operates as a biopharmaceutical company dedicated to discovering and advancing novel therapeutic candidates and diagnostic solutions for a range of metabolic and liver-related diseases. Its most advanced drug candidate, Elafibranor, is currently undergoing Phase 3 clinical evaluation for the treatment of primary biliary cholangitis (PBC). Beyond therapeutics, Genfit is also developing its NIS4 technology, designed to aid in the diagnosis of nonalcoholic steatohepatitis (NASH) and fibrosis. The company's pipeline further encompasses GNS561, which is in Phase 1b/2 trials for cholangiocarcinoma (CCA), and Nitazoxanide, undergoing Phase 1 evaluation as a potential therapy for acute-on-chronic liver failure. Genfit has established strategic partnerships, including a licensing agreement with Labcorp for the commercialization of NASHnext, a blood-based molecular diagnostic test. Additionally, it collaborates with Genoscience Pharma to jointly develop and market the investigational treatment GNS561 for CCA. Founded in 1999, Genfit S.A. is headquartered in Loos, France.

Key metrics

Market cap

$445.68M

P/E (TTM)

-9.94

EPS (TTM)

$-0.90

Beta

0.87

Dividend yield

0.00%

Revenue / share

$1.35

50-day avg

$4.12

200-day avg

$3.94

52-week high

$10.00

52-week low

$2.55

CEO

M. Pascal Prigent

ETFs linked to GNFT

Broad-market and Healthcare sector ETFs an investor holding Genfit S.A. is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how GNFT fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze GNFT in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Genfit S.A.?: Genfit S.A. trades under the ticker GNFT on NASDAQ.
Which exchange is GNFT listed on?: GNFT is listed on NASDAQ.
What sector does Genfit S.A. operate in?: Genfit S.A. is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze GNFT in a portfolio?: PortView shows GNFT's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.